Blood cancer Clinical Trials in Los Angeles, CA

As of September 2026, 69 paid clinical trials are recruiting for Blood cancer in Los Angeles, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

70 clinical trials for Blood cancer

·Clear filters·

Email me when a new blood cancer trial opens in Los Angeles, CA.

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Los Angeles, Fresno +214 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06317649·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for Hematopoietic and Lymphatic System Neoplasm

Sites in Los Angeles, Duarte +189 more locations

Sponsor: Children's Oncology Group

Sex: Female·Age: Up to 39

Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Los Angeles, Santa Clara +170 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554393·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

Sites in Los Angeles, Downey +185 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting·Listed May 2019

Apply to this trial

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

Sites in Los Angeles +93 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06649812·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

Sites in Los Angeles, Downey +167 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

Sites in Los Angeles, Downey +225 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting·Listed Mar 2015

Apply to this trial

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for Acute Lymphoblastic Leukemia

Sites in Los Angeles, Downey +154 more locations

Sponsor: PedAL BCU, LLC

Sex: All·Age: Up to 22

Code: NCT04726241·Phase 1, Phase 2·Recruiting·Listed Jan 2021

Apply to this trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

Sites in Los Angeles, Santa Barbara +144 more locations

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting·Listed Feb 2016

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

Sites in Los Angeles, Glendale +111 more locations

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting·Listed May 2011

Apply to this trial

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

for Hematopoietic and Lymphatic System Neoplasm

1 location in Los Angeles

Sponsor: University of Southern California

Sex: All·Age: 18+

Code: NCT07306338·Recruiting·Listed Dec 2025

Apply to this trial

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

for Mantle Cell Lymphoma

Drug: Glofitamab

Sites in Los Angeles, San Francisco & Davis

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT06252675·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for Multiple Myeloma

Drug: Teclistamab

Sites in Los Angeles, San Diego +39 more locations

Sponsor: European Myeloma Network B.V.

Sex: All·Age: 18+

Code: NCT05243797·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

for Lymphoma

Sites in Los Angeles +2 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 5+·Accepts healthy volunteers

Code: NCT05237986·Recruiting·Listed Feb 2022

Apply to this trial

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

for B-All

Sites in Los Angeles +7 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 1 - 25

Code: NCT05621291·Recruiting·Listed Nov 2022

Apply to this trial

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

for Hematologic Malignancy

1 location in Los Angeles

Sponsor: Joshua Sasine, MD, PhD

Sex: All·Age: 18 - 85

Code: NCT05887167·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

for Hematologic Malignancies

1 location in Los Angeles

Sponsor: Ronald Paquette

Sex: All·Age: 65+

Code: NCT05849207·Phase 1·Recruiting·Listed May 2023

Apply to this trial

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for Acute Biphenotypic Leukemia

Sites in Los Angeles +7 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 6 Months - 26·Accepts healthy volunteers

Code: NCT03779854·Phase 2·Recruiting·Listed Dec 2018

Apply to this trial

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

for Acute Myeloid Leukemia

1 location in Los Angeles

Sponsor: University of Southern California

Sex: All·Age: 18+

Code: NCT03921047·Recruiting·Listed Apr 2019

Apply to this trial

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

for Acute Lymphoblastic Leukemia

2 locations in Los Angeles

Sponsor: University of Southern California

Sex: All·Age: 18+

Code: NCT03568266·Recruiting·Listed Jun 2018

Apply to this trial

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for Hematopoietic and Lymphatic System Neoplasm

Sites in Los Angeles, Downey +74 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 15 - 20

Code: NCT06410209·Phase 2·Recruiting·Listed May 2024

Apply to this trial

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

for Healthy Subject

1 location in Los Angeles

Sponsor: University of Southern California

Sex: All·Age: 19+·Accepts healthy volunteers

Code: NCT03207854·Recruiting·Listed Jul 2017

Apply to this trial

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

for Clonal Cytopenia of Undetermined Significance

2 locations in Los Angeles

Sponsor: University of Southern California

Sex: All·Age: 18+

Code: NCT06063486·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for Grade 3b Follicular Lymphoma

Sites in Los Angeles, Beverly Hills +97 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05890352·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

for Diffuse Large B-Cell Lymphoma

Sites in Los Angeles, Sacramento +1 more location

Sponsor: Jonsson Comprehensive Cancer Center

Sex: All·Age: 18 - 70

Code: NCT05256641·Phase 1, Phase 2·Recruiting·Listed Feb 2022

Apply to this trial

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

for Leukemia

1 location in Los Angeles

Sponsor: Children's Hospital Los Angeles

Sex: All·Age: 3+·Accepts healthy volunteers

Code: NCT06360718·Recruiting·Listed Apr 2024

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

Sites in Los Angeles, Orange +27 more locations

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Los Angeles, Clovis +2 more locations

Sponsor: Brian Jonas

Sex: All·Age: 18+

Code: NCT04905810·Phase 2·Recruiting·Listed May 2021

Apply to this trial

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for Multiple Myeloma

Sites in Los Angeles +10 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05714839·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

Conditions in Blood cancer (Los Angeles, CA)

Acute myeloid leukemia (AML)· 16 Hematologic malignancy· 14 Multiple myeloma· 13 Diffuse large B-cell lymphoma (DLBCL)· 11 Leukemia (other)· 10 Myelodysplastic syndromes (MDS)· 9 Non-Hodgkin lymphoma· 8 Chronic lymphocytic leukemia (CLL)· 6 Acute lymphoblastic leukemia· 6 Myelofibrosis· 4 Mantle cell lymphoma· 4 Chronic myelomonocytic leukemia· 3 Small lymphocytic lymphoma· 3 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Follicular lymphoma· 2 Burkitt lymphoma· 2 Marginal zone lymphoma· 1